Related Experiment Video
Updated: Feb 8, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Sudden death risk markers for patients with left ventricular ejection fractions greater than 40
Brian P Halliday1, Amrit S Lota1, Sanjay K Prasad1
1CMR Unit and Cardiovascular Research Centre, Royal Brompton Hospital, National Heart & Lung Institute, Imperial College, Sydney Street, SW3 6NP London, United Kingdom.
Insights
Sudden cardiac death (SCD) poses a significant risk for patients with heart disease and preserved ejection fraction (LVEF > 40%). Identifying high-risk individuals is crucial for effective intervention and preventing life-threatening arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Preventive Medicine
Background:
- Sudden cardiac death (SCD) is a major concern in heart disease patients.
- A significant portion of SCD occurs in patients with left ventricular ejection fraction (LVEF) greater than 40%.
Purpose of the Study:
- To identify features that predict SCD risk in patients with LVEF > 40%.
- To explore the potential benefit of implantable cardioverter defibrillators (ICDs) in this patient subgroup.
- To review existing literature on SCD markers in patients with preserved LVEF.
Main Methods:
- Literature review of studies examining SCD risk markers.
- Analysis of patient data focusing on LVEF > 40%.
- Discussion of current evidence gaps.
Main Results:
- Patients with LVEF > 40% have a lower annual SCD risk but potentially higher cumulative lifetime risk.
- The need for identifying high-risk individuals within this group is emphasized.
- Current evidence on specific SCD markers for this subgroup is limited.
Conclusions:
- Urgent need for reliable markers to identify patients with LVEF > 40% at high risk of SCD.
- Further research is required to guide prophylactic strategies, including ICD implantation, in this population.
Abstract:
The major burden of sudden cardiac death (SCD) in patients with heart disease occurs in those with a left ventricular ejection fraction > 40%. Although the annual risk of SCD may be lower in these patients compared to those with lower LVEF, their lifetime cumulative risk of SCD may be greater due to a better overall prognosis. It is plausible that those with LVEF > 40% who are at highest risk of life-threatening arrhythmia will benefit from implantable cardioverter defibrillators. Features that identify patients with a LVEF > 40% at high risk of SCD are urgently needed. We review existing studies examining SCD markers in this sub-group and discuss gaps in the current evidence base.
Related Concept Videos
Relative Risk
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Partial Fractions
Subcellular Fractionation
Differential Centrifugation
Differential centrifugation is...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

